Azhar Mehmood | Cancer Genetics | Best Researcher Award

Dr. Azhar Mehmood | Cancer Genetics
| Best Researcher Award

Rawalpindi Medical University | Pakistan

Dr. Azhar Mehmood is a biochemistry and molecular biology researcher whose work spans cancer genetics, DNA damage response pathways, exosomal biomarker discovery, and infectious disease molecular diagnostics. His research contributions include extensive investigation of breast, gastric, thyroid, and head and neck cancers, with a strong emphasis on genetic polymorphisms, pathway deregulation, epigenetic mechanisms, and survival-associated molecular markers. He has explored the prognostic significance of DDR pathway genes, including ATM, ATR, Chk1, and SIRT3/FOXO3a/SOD2 regulatory axes, and conducted SNP-based risk analyses for various malignancies. His work on exosomal microRNAs—such as miR-19a/b, miR-144-3p, miR-4262, and the miR-17-92a cluster—has advanced understanding of their diagnostic and therapeutic potential in breast and brain tumors. His research background also includes contributions to molecular profiling of HCV persistence, viral immunology, and transfusion-transmitted infections. He has applied molecular techniques such as qPCR, LORD-qPCR, IHC, ELISA, genotyping, exosome characterization, and multiple biochemical assays to uncover disease mechanisms and improve diagnostic precision. His publications collectively highlight a strong focus on cancer risk assessment, biomarker identification, and translational molecular research aimed at supporting early detection, targeted therapy development, and improved patient outcomes across multiple cancer types.

Featured Publications

Haris, M. S., Hussain, M. Z., Mehmood, A., Kayani, M. A., & Mahjabeen, I. (2025). hsa-miR-144-3p and hsa-miR-4262 are exosomal biomarkers and function as tumor suppressors in HCMV positive brain tumor. Future Oncology. https://doi.org/10.1080/14796694.2025.2569097

Mehmood, A., Mahjabeen, I., Reed, S., Errington, R. J., Umar, M., Pervaiz, F., & Kayani, M. A. (2025). Association of DDR pathway proteins and breast cancer risk in a Pakistani population. Future Oncology. https://doi.org/10.1080/14796694.2025.2581508

Krishnamoorthi R | Bioengineering | Young Scientist Award

Dr. Krishnamoorthi R | Bioengineering
| Young Scientist Award

Chang Gung University | Taiwan

Dr. R. Krishnamoorthi is an accomplished researcher specializing in nanomedicine, biomaterials, and drug delivery systems, with a strong foundation in microbiology and biomedical applications. His research focuses on the development of innovative nanostructures, including silver-gold nanocomposites, bacteriocin-functionalized nanoparticles, and bioengineered hydrogels, for antimicrobial, antioxidant, anticancer, and wound-healing therapies. He has significantly contributed to interdisciplinary research integrating nanotechnology, immunomodulatory biomaterials, and probiotics for therapeutic advancement. With over 25 peer-reviewed publications in high-impact journals such as International Journal of Biological Macromolecules, Bioorganic Chemistry, and Fish & Shellfish Immunology, his cumulative impact factor exceeds 130. His current postdoctoral research at Chang Gung University, Taiwan, emphasizes microbial biosurfactants, nanoscale drug carriers, and in silico approaches for biomedical innovation. He has also contributed to the discovery and characterization of novel probiotic strains and their exopolysaccharides with potent bioactivities. Additionally, his work extends to developing green synthesis methods for metal oxide nanoparticles and investigating their electrochemical, antibacterial, and antioxidant properties. Dr. Krishnamoorthi’s research represents a synthesis of biological and material sciences aimed at sustainable, targeted, and biocompatible solutions for global healthcare challenges.

Featured Publications

Krishnamoorthi, R., Srinivash, M., Mahalingam, P. U., & Malaikozhundan, B. (2022). Dietary nutrients in edible mushroom, Agaricus bisporus and their radical scavenging, antibacterial, and antifungal effects. Process Biochemistry, 121, 10–17.

 Chinnaiah, K., Krishnamoorthi, R., Kannan, K., Sivaganesh, D., & [additional authors if any]. (2022). Ag nanoparticles synthesized by Datura metel L. leaf extract and their charge density distribution, electrochemical and biological performance. Chemical Physics Letters, 807, 140083.

 Krishnamoorthi, R., Srinivash, M., Mahalingam, P. U., Malaikozhundan, B., & [additional authors if any]. (2022). Antimicrobial, anti-biofilm, antioxidant and cytotoxic effects of bacteriocin by Lactococcus lactis strain CH3 isolated from fermented dairy products—An in vitro and in silico study. International Journal of Biological Macromolecules, 220, 291–306.

 Chinnaiah, K., Kannan, K., Krishnamoorthi, R., Palko, N., & Gurushankar, K. (2024). Nanostructured Ag/NiO composites for supercapacitor and antibacterial applications, and in-silico theoretical investigation. Journal of Physics and Chemistry of Solids, 184, 111730.

Krishnamoorthi, R., Mahalingam, P. U., & Malaikozhundan, B. (2022). Edible mushroom extract engineered Ag NPs as safe antimicrobial and antioxidant agents with no significant cytotoxicity on human dermal fibroblast cells. Inorganic Chemistry Communications, 139, 109362.